ZIVO BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised
ZIVO BIOSCIENCE, INC. (ZIVO) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised of 139.10 thousand shares for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-14.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised · last filed 2023-03-14
- ZIVO BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2021-12-31 was -564.00 shares, a 190.24% decline year-over-year.
- ZIVO BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2021-09-30 was 564.00 shares, a 95.35% decline year-over-year.
- ZIVO BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2021-06-30 was 138.47K shares.
- ZIVO BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2021-03-31 was 625.00 shares.
- ZIVO BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2022 was 139.10K shares, a 0.00% change from fiscal 2021.
- ZIVO BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2021 was 139.10K shares, a 96.96% increase from fiscal 2020.
- ZIVO BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2020 was 70.63K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 12 month |
|---|---|---|---|---|---|---|---|
| 2022-12-31 | 139.10K shares 10-K · filed 2023-03-14 | ||||||
| 2022-06-30 | 139.66K shares 10-Q · filed 2022-08-04 | ||||||
| 2021-12-31 | -564.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-22 | 0.00 shares derived: sum of 2 quarters · filed 2022-11-14 | 138.47K shares derived: sum of 3 quarters · filed 2022-11-14 | 139.10K shares 10-K · filed 2022-04-22 | |||
| 2021-09-30 | 198.50K shares 10-K · filed 2023-03-14 | 198.50K shares 10-Q/A · filed 2022-04-21 | 564.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 139.04K shares derived: sum of 2 quarters · filed 2022-11-14 | 139.66K shares 10-Q · filed 2022-11-14 | 139.10K shares 10-Q · filed 2021-11-15 | 140.29K shares derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | 138.47K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | 139.10K shares 10-Q · filed 2021-08-16 | 139.72K shares derived: sum of 3 quarters · filed 2022-05-13 | 151.85K shares derived: sum of 4 quarters · filed 2022-05-13 | |||
| 2021-03-31 | 625.00 shares 10-Q · filed 2022-05-13 | 1.25K shares derived: sum of 2 quarters · filed 2022-05-13 | 13.38K shares derived: sum of 3 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | 625.00 shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-04-22 | 12.75K shares derived: sum of 2 quarters · filed 2022-04-22 | 70.63K shares 10-K · filed 2022-04-22 | ||||
| 2020-09-30 | 12.13K shares derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-04-21 | 70.00K shares 10-Q/A · filed 2022-04-21 | |||||
| 2020-06-30 | 57.88K shares 10-Q · filed 2021-08-16 |